loading

Finanzdaten der Eloxx Pharmaceuticals Inc-Aktie (ELOX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Expenses
17.26%
4.45
3.795 3.637 4.14 5.483
Operating Income/Loss
17.26%
-4.45
-3.795 -3.637 -4.14 -5.483
Net Income/Loss
19.93%
-4.502
-3.754 -3.592 -4.341 -6.23
Basic Average Shares
85.92%
6.7892
48.21 2.7477 2.2124 2.1664
Diluted Average Shares
85.92%
6.7892
48.21 2.7477 2.2124 2.1664
Basic Earnings Per Share
725.00%
-0.66
-0.08 -1.31 -1.96 -2.88
Diluted Earnings Per Share
725.00%
-0.66
-0.08 -1.31 -1.96 -2.88
$7.50
price up icon 1.35%
$10.27
price up icon 0.39%
$5.74
price up icon 5.03%
$18.93
price up icon 5.17%
$10.91
price up icon 6.03%
WVE WVE
$3.19
price up icon 3.24%
Kapitalisierung:     |  Volumen (24h):